We are live on ! Find out more
INO icon

Inovio Pharmaceuticals
INO

107 hedge funds and large institutions have $22.2M invested in Inovio Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 34 increasing their positions, 27 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,018% more call options, than puts

Call options by funds: $436K | Put options by funds: $39K

31% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 13

26% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 27

3% more funds holding

Funds holding: 104 → 107 (+3)

0.07% more ownership

Funds ownership: 37.02% → 37.09% (+0.07%)

9% less capital invested

Capital invested by funds: $24.5M → $22.2M (-$2.3M)

Holders
107
Holders Change
+3
Holders Change %
+2.88%
% of All Funds
1.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
34
Reduced
27
Closed
13
Calls
$436K
Puts
$39K
Net Calls
+$397K
Net Calls Change
+$103K

Top Buyers

1
Bank of America
Bank of America
North Carolina
+$1.33M
2
BlackRock
BlackRock
New York
+$823K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$713K
4
Northern Trust
Northern Trust
Illinois
+$495K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$438K

Top Sellers

1
ACM
AIGH Capital Management
Maryland
-$1.2M
2
SCM
Stonepine Capital Management
Oregon
-$1.07M
3
HCM
Highbridge Capital Management
New York
-$549K
4
Renaissance Technologies
Renaissance Technologies
New York
-$394K
5
UOC
UBS O'Connor
Illinois
-$393K
Name Holding Trade Value Shares
Change 		Change in
Stake
DTC
1
Deep Track Capital
Connecticut
$5.08M – – –
BlackRock
2
BlackRock
New York
$3.78M +$823K +409,969 +21%
Vanguard Group
3
Vanguard Group
Pennsylvania
$3.31M +$713K +355,372 +21%
Bank of America
4
Bank of America
North Carolina
$2.13M +$1.33M +664,000 +104%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$1.38M +$438K +218,298 +35%
SCM
6
Stonepine Capital Management
Oregon
$845K -$1.07M -531,669 -51%
State Street
7
State Street
Massachusetts
$838K +$19.7K +9,840 +2%
Northern Trust
8
Northern Trust
Illinois
$759K +$495K +246,721 +113%
Morgan Stanley
9
Morgan Stanley
New York
$464K +$304K +151,366 +114%
UBS Group
10
UBS Group
Switzerland
$339K +$62K +30,893 +17%
Susquehanna International Group
11
Susquehanna International Group
Pennsylvania
$317K +$305K +152,200 +361%
Goldman Sachs
12
Goldman Sachs
New York
$213K -$321K -159,902 -55%
GC
13
GMT Capital
Georgia
$206K -$4 -2 -0%
N
14
Nuveen
North Carolina
$168K +$114K +56,806 +122%
Fidelity Investments
15
Fidelity Investments
Massachusetts
$164K +$38.7K +19,295 +24%
Charles Schwab
16
Charles Schwab
California
$161K +$55K +27,429 +39%
Bank of New York Mellon
17
Bank of New York Mellon
New York
$123K +$27.7K +13,784 +22%
AQR Capital Management
18
AQR Capital Management
Connecticut
$120K +$148K +73,575 New
Two Sigma Investments
19
Two Sigma Investments
New York
$118K +$145K +72,364 New
XT
20
XTX Topco
Cayman Islands
$108K +$28K +13,939 +27%
GAA
21
Green Alpha Advisors
Colorado
$99.9K -$8.4K -4,185 -6%
SEI Investments
22
SEI Investments
Pennsylvania
$92.6K +$114K +56,806 New
CIA
23
Concurrent Investment Advisors
Florida
$89.7K +$110K +55,011 New
Bank of Montreal
24
Bank of Montreal
Ontario, Canada
$76.3K +$46.8K +23,341 +99%
Renaissance Technologies
25
Renaissance Technologies
New York
$74.7K -$394K -196,477 -81%
1
2 3 4 5

INO Hedge Fund Activity: Q1 2025 in Review

107 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in Inovio Pharmaceuticals (INO) for Q1 2025, worth a combined $22.2M — down 9.4% from $24.5M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new INO positions and 13 closed out — a net gain of 4 holders — while 34 added to existing stakes and 27 trimmed.

The largest buyer was Bank of America, adding an estimated $1.33M. The largest seller was AIGH Capital Management, exiting entirely with an estimated $1.2M sold.

  • 107 institutional investors held Inovio Pharmaceuticals (INO) as of Q1 2025, up from 104 in Q4 2024.
  • Funds reported $22.2M of Inovio Pharmaceuticals stock for Q1 2025, down 9.4% quarter-over-quarter.
  • 17 funds opened new Inovio Pharmaceuticals positions in Q1 2025 and 13 closed out, a net change of +4 holders.
  • The largest Inovio Pharmaceuticals buyer in Q1 2025 was Bank of America, an estimated $1.33M added.
  • The largest Inovio Pharmaceuticals seller in Q1 2025 was AIGH Capital Management, an estimated $1.2M sold.

Based on aggregated 13F filings for Q1 2025.